Scientific Name | Pharmaceutical form | Strength Value |
---|---|---|
Inactivated Newcastle Disease virus Ulster 2C strain/ Inactivated Infectious Bursal Disease virus VNJO strain |
Emulsion for injection |
NLT 50- , NLT 5- |
Inactivated Newcastle Disease virus Ulster 2C strain/ Inactivated Infectious Bronchitis virus Mass 41 strain/ Inactivated Infectious Bursal Disease virus VNJO strain |
Emulsion for injection |
NLT 50- , NLT 80- , NLT 5- |
Inactivated Newcastle Disease virus Ulster 2C strain |
Emulsion for injection |
NLT 50- |
Live attenuated fowl pox virus DCEP25 strain |
Lyophilisate and solvent for suspension for injection |
NLT 3.0- |
Attenuated Infectious Bronchitis Coronavirus strain CR88121 |
Effervescent tablet |
NLT 4.0- |
Avian Encephalomyelitis Virus/ Fowl Pox Virus |
Lyophilisate and solvent for suspension for injection |
NLT 10ˆ2.7- , NLT 10ˆ2.2- |
Inactivated Mycoplasma agalactiae N84 strain/Inactivated Mycoplasma capricolum strain 27343/ Inactivated Mycoplasma mycoides subsp mycoides HH strain |
Suspension for injection |
1:20U , 1:20U , 1:20U |
Attenuated feline rhinotracheitis herpesvirus- FHV F2 strain/ Inactivated feline Calicivirosis antigens- FCV 431 and G1 strains/ Attenuated feline panleucopenia virus- PLI IV |
Lyophilisate and solvent for suspension for injection |
NLT 10ˆ4.9- , NLT 2.0- , NLT 10ˆ3.5- |
Streptococcus iniae antigin |
Suspension for injection |
1×10^10cells/ml |
Mareks Disease Rispens CVI988 Strain |
Suspension for injection |
1608PFU/dose |